11. New and repurposed drugs 179 Maria Krutikov, Judith Bruchfeld, Giovanni Battista Migliori, Sergey Borisov and Simon Tiberi 12. Adverse anti-tuberculosis drug events and their management 205 José A. Caminero, Paula Lasserra, Alberto Piubello and Rupak Singla 13. Surgery as a treatment 228 Anne Olland, Pierre-Emmanuel Falcoz, Sophie Guinard, Joseph Seitlinger and Gilbert Massard 14. Challenges in childhood tuberculosis 234 H. Simon Schaaf, Ben J. Marais, Isabel Carvalho and James A. Seddon 15. Pregnancy and the elderly 263 Alice Repossi and Graham Bothamley 16. Comorbidities 276 Cecile Magis-Escurra, Anna Cristina C. Carvalho, Afrânio L. Kritski and Enrico Girardi 17. Access and adherence to prevention and care for hard-to-reach groups 291 Kerri Viney, Tom Wingfield, Liga Kuksa and Knut Lönnroth 18. Monitoring during and after treatment 308 Jan-Willem C. Alffenaar, Onno W. Akkerman and Graham Bothamley 19. Sequelae assessment and rehabilitation 326 Marcela Muñoz-Torrico, Silvia Cid-Juárez, Susana Galicia-Amor, Thierry Troosters and Antonio Spanevello 20. Towards a new vaccine 343 Morten Ruhwald, Peter L. Andersen and Lewis Schrager 21. Transmission control: a refocused approach 364 Edward Nardell and Grigory Volchenkov 22. Diagnosis and treatment of latent tuberculosis infection 381 Adrian Rendon, Delia Goletti and Alberto Matteelli 23. Nontuberculous mycobacteria 399 Sanne Zweijpfenning, Wouter Hoefsloot and Jakko van Ingen 24. What next? Basic research, new treatments and a patient-centred 414 approach Graham Bothamley 25. Opportunities for training and learning 430 Caterina Casalini, Alberto Matteelli, Albert Komba, Lia D’Ambrosio and Jan van den Hombergh Clinical cases 446 Simon Tiberi, Marie Christine Payen, Katerina Manika, Inês Ladeira, Marta Gonzalez Sanz and Marcela Muñoz-Torrico
Previous Page Next Page